ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,284Medicare Part D Prescriptions Filled, Including Refills

Rank: 647 out of 3001

$513K Total Retail Price of All Prescriptions

Rank: 611 out of 3001

199 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 199 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 199 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 5,212 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
FUROSEMIDE 423 328 1 6
LISINOPRIL 229 173 2 2
HYDROCODONE-ACETAMINOPHEN 229 97 S3 2 7
LEVOTHYROXINE SODIUM 205 164 4 3
SIMVASTATIN 187 130 5 1
WARFARIN SODIUM 178 159 6 12
AMLODIPINE BESYLATE 176 156 7 5
RISPERIDONE 170 111 8 63
OMEPRAZOLE 147 104 9 4
MIRTAZAPINE 137 106 10 44
METOPROLOL TARTRATE 120 98 11 8
QUETIAPINE FUMARATE 117 57 12 66
TRAMADOL HCL 113 64 13 17
CLOZAPINE 109 14 14 170
LEVEMIR 100 75 15 204
DONEPEZIL HCL 100 91 15 27
FENTANYL 96 55 S2 17 76
SERTRALINE HCL 95 60 18 20
POTASSIUM CHLORIDE 91 62 19 15
BENZTROPINE MESYLATE 89 37 R 20 127
METHYLPHENIDATE HCL 83 36 21 401
GABAPENTIN 81 49 22 14
LEVETIRACETAM 81 41 22 112
IPRATROPIUM-ALBUTEROL 76 35 24 119
EXELON 74 61 25 108
ZOLPIDEM TARTRATE 73 26 26 24
ATENOLOL 71 42 27 18
OXYCODONE-ACETAMINOPHEN 71 60 S2 27 32
TRAZODONE HCL 70 28 29 37
AMOX TR-POTASSIUM CLAVULANATE 67 48 30 143
FAMOTIDINE 64 43 31 68
NAMENDA 64 50 31 40
JANTOVEN 61 39 33 110
ABILIFY 58 28 34 144
LANTUS 56 23 35 47
BACLOFEN 55 25 36 125
ADVAIR DISKUS 55 27 36 58
ISOSORBIDE MONONITRATE ER 55 52 36 45
CITALOPRAM HBR 55 32 36 16
CARVEDILOL 54 30 40 25
NOVOLOG 54 36 40 94
MIDODRINE HCL 54 26 40 305
GLIMEPIRIDE 54 39 40 31
METFORMIN HCL 50 33 44 9
MEGESTROL ACETATE 50 46 R 44 200
DOXYCYCLINE HYCLATE 50 36 44 105
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 17, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.